You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
AstraZeneca
Harvard Business School
Boehringer Ingelheim
McKinsey

Last Updated: May 25, 2020

DrugPatentWatch Database Preview

OCUSULF-30 Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Ocusulf-30, and when can generic versions of Ocusulf-30 launch?

Ocusulf-30 is a drug marketed by Miza Pharms Usa and is included in one NDA.

The generic ingredient in OCUSULF-30 is sulfacetamide sodium. There are three drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.

US ANDA Litigation and Generic Entry Outlook for Ocusulf-30

A generic version of OCUSULF-30 was approved as sulfacetamide sodium by SANDOZ INC on October 18th, 1988.

  Start Trial

Summary for OCUSULF-30
Drug patent expirations by year for OCUSULF-30
Synonyms for OCUSULF-30
144-80-9
27890-59-1
4-[(acetylamino) sulfonyl]aniline
4-[(acetylamino)sulfonyl]aniline
4-14-00-02662 (Beilstein Handbook Reference)
4-acetylaminosulfonylaniline
4965G3J0F5
5414-91-5
A-500
AB00052094_14
AB1009295
AC-7630
Acetamide, N-((4-aminophenyl)sulfonyl)-
Acetamide, N-[(4-aminophenyl)sulfonyl]-
Acetamide, N-[(4-aminophenyl)sulfonyl]-, monosodium salt
Acetamide, N-[(4-aminophenyl)sulfonyl]-, sodium salt (1:1)
Acetamide, N-sulfanilyl-
Acetocid
Acetosulfamin
Acetosulfamine
ACMC-1BRAE
AI3-26837
AK-77664
AKOS000119729
Albamine
Albucid
Alesten
ANW-41556
ARONIS022108
BBL012083
BDBM50316126
Bleph-10
Bleph-10 liquifilm
BLEPH-30
BPBio1_000053
BRD-K21520694-001-12-3
BRN 0981718
BSPBio_000047
BSPBio_002773
CAS-144-80-9
Caswell No. 808A
CBChromo1_000180
CBDivE_013934
CCG-39256
CCRIS 6273
CETAPRED
CHEBI:63845
CHEMBL455
CPD000058173
CS-0013812
CTK4J9771
D05947
DB-042749
DB00634
DivK1c_000227
DSSTox_CID_6060
DSSTox_GSID_26060
DSSTox_RID_78000
DTXSID8026060
EINECS 205-640-6
EPA Pesticide Chemical Code 077904
FML-S
Formosulfacetamide
FT-0631838
HMS1921A11
HMS2092I13
HMS2232K07
HMS3259G06
HMS3374O02
HMS500L09
HTS000803
HY-N7123
IDI1_000227
Isopto cetamide
KBio1_000227
KBio2_001464
KBio2_004032
KBio2_006600
KBio3_001993
KBioGR_001691
KBioSS_001464
Klaron
KS-000009VL
KS-00004DFL
KS-5327
LS-852
MCULE-7029640696
Metimyd
MFCD00066501
MLS000069710
MLS001076499
N-((4-Aminophenyl)sulfonyl)acetamide
N-((p-Aminophenyl)sulfonyl)acetamide
N-(4-Aminobenzenesulfonyl)acetamide
N-(4-Aminobenzenesulfonyl)acetamide; N-(4-Aminophenylsulfonyl)acetamide; N1-Acetylsulfanilamide
N-(4-aminophenyl)sulfonylacetamide
N-(4-Aminophenylsulfonyl)acetamide
N-(p-Aminobenzenesulfonyl)acetamide
N-[(4-aminobenzene)sulfonyl]acetamide
N-[(4-Aminophenyl)sulfonyl]acetamide
N-[(p-Aminophenyl)sulfonyl]acetamide
N-acetyl-4-amino-benzenesulfonamide
N-Acetyl-4-aminobenzenesulfonamide
N-Acetylsulfanilamide
N-Acetylsulfanilamine
N-Sulfanilylacetamide
N-Sulphanilylacetamide
N'-Acetylsulfanilamide
N(1)-acetyl-4-aminophenylsulfonamide
N(1)-acetylsulfanilamide
N(sup 1)-Acetyl-4-aminophenylsulfonamide
N(sup 1)-Acetylsulfanilamide
N(sup1)-Acetylsulfanilamide
N1-Acetylsulfanilamide
NC00538
NCGC00018242-01
NCGC00018242-02
NCGC00018242-03
NCGC00018242-04
NCGC00018242-05
NCGC00018242-06
NCGC00018242-07
NCGC00018242-08
NCGC00021857-03
NCGC00021857-04
NCGC00021857-05
NCGC00257159-01
NCGC00259548-01
NCIOpen2_002838
NE11147
NINDS_000227
NSC 63871
NSC-63871
NSC-757323
NSC63871
NSC757323
Oclucid
Ocusulf-10
OP-Sulfa 30
Opera_ID_1990
Ophthel-S
Oprea1_686524
Oprea1_810285
p-Aminobenzenesulfonacetamide
p-Aminobenzenesulfonoacetamide
Pharmakon1600-01500545
PREDAMIDE
Prestwick0_000014
Prestwick1_000014
Prestwick2_000014
Prestwick3_000014
Q-201757
Q2022983
Region
S0577
s5546
SAM002554931
SBB056763
SBI-0051519.P003
SC-80103
SCHEMBL40863
Sebizon
SKIVFJLNDNKQPD-UHFFFAOYSA-N
SMR000058173
Solfacetamide
Solfacetamide [DCIT]
SPBio_001415
SPBio_001968
Spectrum_000984
SPECTRUM1500545
Spectrum2_001318
Spectrum3_001017
Spectrum4_001146
Spectrum5_001230
SR-01000000194
SR-01000000194-2
ST040726
ST24031284
Steramide
STK068185
Sulamyd
Sulf-10
Sulf-15
Sulfacel-15
Sulfacet
Sulfacetamida
Sulfacetamida [INN-Spanish]
sulfacetamide
SULFACETAMIDE (TRIPLE SULFA)
Sulfacetamide (USP/INN)
Sulfacetamide [USAN:INN]
Sulfacetamide [USP:INN:BAN]
Sulfacetamide 100 microg/mL in Acetonitrile
Sulfacetamide 100 microg/mL in Methanol
SULFACETAMIDE FREE BASE
Sulfacetamide Monosodium Salt
Sulfacetamide, >=98.0%
Sulfacetamide, >=98.0% (NT)
Sulfacetamide, 1
Sulfacetamide, 98%
Sulfacetamide, Antibiotic for Culture Media Use Only
Sulfacetamide, United States Pharmacopeia (USP) Reference Standard
Sulfacetamide, VETRANAL(TM), analytical standard
Sulfacetamidum
Sulfacetamidum [INN-Latin]
Sulfacetimide
Sulfacil
Sulfacyl
Sulfacyl (VAN)
Sulfacylum
Sulfair-15
Sulfanilacetamide
Sulfanilamide, N(sup 1)-acetyl-
Sulfanilamide, N1-acetyl-
Sulfanilazetamid
Sulfanilazetamid [German]
Sulphacetamide
Sulphacetamidum
Sulphasil
SULSTER
Sulten-10
SY014752
Tox21_110846
Tox21_110846_1
Tox21_201999
Tox21_303100
TR-005664
TRA0027310
UNII-4965G3J0F5
Urosulfon
Urosulfone
WLN: ZR DSWMV1
ZINC5179119

US Patents and Regulatory Information for OCUSULF-30

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Miza Pharms Usa OCUSULF-30 sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 080660-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
AstraZeneca
Harvard Business School
Boehringer Ingelheim
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.